Key result
OncoActive pilot intervention increases active days by ~39% among survivors.
Why the study?
Does the OncoActive computer-tailored physical activity intervention increase physical activity in prostate and colorectal cancer patients and survivors compared to usual care?
Population
Prostate and colorectal cancer patients and survivors (n=428 for the ongoing RCT) in the Netherlands.
Comparison
OncoActive intervention: a computer-tailored… vs Usual care waiting-list control group
Design
Other, Randomized controlled trial (for the ongoing evaluation)
Follow-up
three, six and twelve months
Authors
Loading...
OncoActive is feasible and safe for prostate/colorectal cancer survivors; RCT needed to determine effects on physical activity.
Does the OncoActive computer-tailored physical activity intervention increase physical activity in prostate and colorectal cancer patients and survivors compared to usual care?
The OncoActive computer-tailored physical activity intervention was systematically developed and found to be feasible and safe for prostate and colorectal cancer survivors, with an RCT currently underway to evaluate its effectiveness.
Golsteijn et al. (2017) studied Prostate and colorectal cancer (n=428). OncoActive (computer-tailored physical activity program) vs. Usual care waiting-list control was evaluated on Physical activity. The OncoActive computer-tailored physical activity intervention was systematically developed and, in a pilot study of 21 survivors, significantly increased the number of days participants were active for at least 30 minutes (3.8 vs. 5.3 days, p=0.005).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: